drugset / Trial / NCT02695004
Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).
RandomizedParallel-groupDouble-blindOther
Summary
This is a study to evaluate safety, tolerability and PK of DKF-310 IM injection in healthy male volunteers.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 35 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 70 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 140 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 210 mg | Intramuscular |
| Subject | Donepezil | Small molecule | 280 mg | Intramuscular |